-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diabetes is known to cause common infections such as cellulitis and pneumonia.
, the correlation between blood sugar control levels and infection rates is not clear.
, researchers analyzed a large queue of diabetics to explore the relationship between blood sugar control and infection rates in diabetics, according to a recent study published in Diabetes Care, an authoritative journal in the field of diabetes.
, the researchers first tested each patient for HbA1c and then retrieved the patient's infection diagnosis within 60 days of the test.
researchers conducted multiple logistic regression analyses to determine the effect of HbA1c on the likelihood of being diagnosed with infection.
researchers were able to control a number of conferencing factors, such as other chronic diseases, the time after diagnosis of diabetes, and the use of steroid drugs before infection.
identified 407 cases of cellulitis.
In 7.5% (58 mmol/mol) patients, the risk of multifaceted regression of cellular tissue inflammation increased by 1.4 times, such as obesity, Parkinson's disease, peripheral vascular disease, and factors susceptible to cellulitis such as previous treatment with pernisone.
for every 1% increase in HbA1c (11 mmol/mol), patients were 12% more likely to develop cellular tissue inflammation (the ratio ratio was 1.12; 95% CI was 1.05-1.19).
similar analysis found an increased risk of pneumonia in patients with HbA1c>7.5% (58 mmol/mol;OR of 1.1; 95% CI of 0.9-1.4).
, poor blood sugar control is associated with the occurrence of cellulitis.
the study also showed that oral nylon therapy increased the risk of cellular tissue inflammation, pneumonia and upper respiratory tract infections.
。